Fingerprint
Dive into the research topics of 'Nintedanib in progressive interstitial lung diseases: data from the whole INBUILD trial'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Nintedanib in progressive interstitial lung diseases: data from the whole INBUILD trial
Kevin R. Flaherty, Athol U. Wells, Vincent Cottin, Anand Devaraj, Yoshikazu Inoue, Luca Richeldi, Simon L.F. Walsh, Martin Kolb, Dirk Koschel, Teng Moua, Susanne Stowasser, Rainer-Georg Goeldner, Rozsa Schlenker-Herceg, Kevin K. Brown
- University of Michigan, Ann Arbor
- Royal Brompton and Harefield Trust
- Universite Claude Bernard Lyon 1
- National Hospital Organization Kinki-Chuo Chest Medical Center
- Imperial College London
- McMaster University
- Fachkrankenhaus Coswig GmbH
- Mayo Clinic Rochester, MN
- Boehringer Ingelheim GmbH
- University of Colorado Denver
Research output: Contribution to journal › Article